Clinical Trial Update: Anti-PD-1 Antibody in the Treatment of Patients With Malignant Melanoma of the Female Genital Tract [Phase 2]

View source ↗

Summary

Phase 2 trial update investigating an anti-PD-1 antibody for malignant melanoma of the female genital tract.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Melanoma of the Female Genital Tract

Drugs mentioned

• Anti-PD-1 antibody

Snippet

Sponsor: Fudan University | Conditions: Malignant Melanoma | Phase 2 | Status: UNKNOWN